Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q22121867> ?p ?o }
Showing triples 1 to 54 of
54
with 100 triples per page.
- Q22121867 subject Q6762709.
- Q22121867 abstract "Juno Therapeutics is a biopharmaceutical company founded in 2013 through a collaboration of the Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center and pediatrics partner Seattle Children's Research Institute. The company was launched with an initial investment of $120 million, with a remit to develop a pipeline of cancer immunotherapy drugs. The company raised $300 million through private funding and a further $265 million through their IPO.".
- Q22121867 foundingYear "2013".
- Q22121867 industry Q7108.
- Q22121867 keyPerson Q484876.
- Q22121867 keyPerson Q5096837.
- Q22121867 keyPerson Q623268.
- Q22121867 keyPerson Q6827278.
- Q22121867 location Q5083.
- Q22121867 type Q891723.
- Q22121867 wikiPageExternalLink junotherapeutics.com.
- Q22121867 wikiPageWikiLink Q1088156.
- Q22121867 wikiPageWikiLink Q1138590.
- Q22121867 wikiPageWikiLink Q1335294.
- Q22121867 wikiPageWikiLink Q1427096.
- Q22121867 wikiPageWikiLink Q1452369.
- Q22121867 wikiPageWikiLink Q156959.
- Q22121867 wikiPageWikiLink Q1808012.
- Q22121867 wikiPageWikiLink Q185142.
- Q22121867 wikiPageWikiLink Q206921.
- Q22121867 wikiPageWikiLink Q264118.
- Q22121867 wikiPageWikiLink Q484876.
- Q22121867 wikiPageWikiLink Q5083.
- Q22121867 wikiPageWikiLink Q5096837.
- Q22121867 wikiPageWikiLink Q623268.
- Q22121867 wikiPageWikiLink Q6762709.
- Q22121867 wikiPageWikiLink Q6827278.
- Q22121867 wikiPageWikiLink Q7108.
- Q22121867 wikiPageWikiLink Q731938.
- Q22121867 wikiPageWikiLink Q7442071.
- Q22121867 wikiPageWikiLink Q842947.
- Q22121867 wikiPageWikiLink Q891723.
- Q22121867 wikiPageWikiLink Q938205.
- Q22121867 foundation "2013".
- Q22121867 industry Q7108.
- Q22121867 keyPeople "Hans Bishop".
- Q22121867 keyPeople "Hyam Levitsky, M.D.".
- Q22121867 keyPeople "Mark Gilbert, M.D.".
- Q22121867 keyPeople "Steve Harr, M.D.".
- Q22121867 location "Seattle, WA".
- Q22121867 name "Juno Therapeutics Inc".
- Q22121867 type Q891723.
- Q22121867 type Organization.
- Q22121867 type Agent.
- Q22121867 type Company.
- Q22121867 type Organisation.
- Q22121867 type Agent.
- Q22121867 type SocialPerson.
- Q22121867 type Thing.
- Q22121867 type Q43229.
- Q22121867 comment "Juno Therapeutics is a biopharmaceutical company founded in 2013 through a collaboration of the Fred Hutchinson Cancer Research Center, Memorial Sloan-Kettering Cancer Center and pediatrics partner Seattle Children's Research Institute. The company was launched with an initial investment of $120 million, with a remit to develop a pipeline of cancer immunotherapy drugs. The company raised $300 million through private funding and a further $265 million through their IPO.".
- Q22121867 label "Juno Therapeutics".
- Q22121867 homepage junotherapeutics.com.
- Q22121867 name "Juno Therapeutics Inc".